At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SOC Sable Offshore Corp.
Market Closed 05-29 16:00:00 EDT
14.65
-0.04
-0.27%
盘后15.77
+1.12+7.65%
19:59 EDT
High14.71Low13.80Vol4.01M
Open14.50D1 Closing14.69Amplitude6.16%
Mkt Cap2.26BTradable Cap1.10BTotal Shares154.36M
T/O57.29MT/O Rate5.33%Tradable Shares75.10M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

District court denies California parks department bid to block Sable Offshore pipeline
Reuters  ·  05-29 05:41
District court denies California parks department bid to block Sable Offshore pipeline
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
GlobeNewswire  ·  05-28 20:00
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
Sable Offshore Corp put volume heavy and directionally bearish
TIPRANKS  ·  05-27
Sable Offshore Corp put volume heavy and directionally bearish
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
GlobeNewswire  ·  05-22
Genmab to Highlight Advances Across Its Oncology Portfolio at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) 2026 Congress
How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy
Simply Wall St.  ·  05-15
How Investors Are Reacting To Sable Offshore (SOC) Deeper Losses And High‑Risk Offshore Restart Strategy
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
GlobeNewswire  ·  05-14
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
prnewswire  ·  05-14
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results
Dow Jones  ·  05-12
Press Release: Sionna Therapeutics Reports First Quarter 2026 Financial Results
Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns
TIPRANKS  ·  05-08
Emerging Growth Status at Sable Offshore Corp. Raises Transparency and Valuation Concerns
Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Dow Jones  ·  05-08
Press Release: IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Sable Offshore (SOC) Receives a Rating Update from a Top Analyst
TIPRANKS  ·  05-08
Sable Offshore (SOC) Receives a Rating Update from a Top Analyst
Sable Offshore Corp reports results for the quarter ended March 31 - Earnings Summary
Reuters  ·  05-07
Sable Offshore Corp reports results for the quarter ended March 31 - Earnings Summary
Sable Offshore Q1 net loss widens 80% to $197.03 million; revenue swings to $1.27 million
Reuters  ·  05-07
Sable Offshore Q1 net loss widens 80% to $197.03 million; revenue swings to $1.27 million
Sable Offshore Corp - Reports Q1 2026 Net Loss of $197.0 Mln
THOMSON REUTERS  ·  05-07
Sable Offshore Corp - Reports Q1 2026 Net Loss of $197.0 Mln
Press Release: Sable Offshore Corp. Reports First Quarter 2026 Financial Results
Dow Jones  ·  05-07
Press Release: Sable Offshore Corp. Reports First Quarter 2026 Financial Results
Assessing Sable Offshore (SOC) Valuation After Upgraded Earnings Forecasts And Positive Analyst Rating
Simply Wall St.  ·  05-06
Assessing Sable Offshore (SOC) Valuation After Upgraded Earnings Forecasts And Positive Analyst Rating
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
GlobeNewswire  ·  05-05
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
GlobeNewswire  ·  05-02
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
Sable Offshore Corp call volume above normal and directionally bullish
TIPRANKS  ·  05-01
Sable Offshore Corp call volume above normal and directionally bullish
Sable Offshore CEO Awarded $76 Million Despite No Oil Sales in 2025
MT Newswires Live  ·  05-01
Sable Offshore CEO Awarded $76 Million Despite No Oil Sales in 2025

Introduction

Company Name.
Sable Offshore Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Flame Acquisition Corp. does not have significant operations. It focuses on effecting into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to identify, acquire, and operate a business in the energy industry primarily upstream exploration and production sector, and midstream sector and companies. Flame Acquisition Corp. was incorporated in 2020 and is based in Houston, Texas.
Issue price:
--